ANDA 88367, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88367 (Lidocaine Hydrochloride In Plastic Container), held by Hospira, was first approved by FDA on Jul 31, 1984, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride In Plastic Container10% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Jan 2, 2002 | Supplement 11Labeling | Approved | None posted |
| Oct 3, 1996 | Supplement 9Manufacturing | Approved | None posted |
| Jul 23, 1991 | Supplement 7Labeling | Approved | None posted |
| Apr 18, 1990 | Supplement 5Labeling | Approved | None posted |
| Oct 14, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Apr 12, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Jul 31, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters